anmelden
SPI
18.552,74
PKT
-22,69
PKT
-0,12
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.05.21 | DocMorris buy | Jefferies & Company Inc. | |
| 06.05.21 | ams-OSRAM Hold | Deutsche Bank AG | |
| 06.05.21 | UBS Neutral | Goldman Sachs Group Inc. | |
| 05.05.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 04.05.21 | ams-OSRAM Underweight | Barclays Capital | |
| 04.05.21 | Nestlé Hold | Deutsche Bank AG | |
| 04.05.21 | ams-OSRAM Underperform | Credit Suisse Group | |
| 04.05.21 | ams-OSRAM overweight | JP Morgan Chase & Co. | |
| 04.05.21 | UBS buy | Deutsche Bank AG | |
| 30.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.21 | Nestlé overweight | JP Morgan Chase & Co. | |
| 30.04.21 | Swiss Re Hold | Jefferies & Company Inc. | |
| 30.04.21 | Nestlé buy | Goldman Sachs Group Inc. | |
| 30.04.21 | DocMorris buy | Baader Bank | |
| 30.04.21 | Novartis buy | Deutsche Bank AG | |
| 30.04.21 | Nestlé add | Baader Bank | |
| 30.04.21 | Swiss Re Outperform | RBC Capital Markets | |
| 30.04.21 | UBS Underweight | Barclays Capital | |
| 30.04.21 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 29.04.21 | Holcim buy | Goldman Sachs Group Inc. | |
| 29.04.21 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 28.04.21 | UBS Sector Perform | RBC Capital Markets | |
| 28.04.21 | Nestlé Hold | Jefferies & Company Inc. | |
| 28.04.21 | UBS Outperform | Credit Suisse Group | |
| 28.04.21 | Novartis Underweight | Barclays Capital | |
| 28.04.21 | Novartis Neutral | Credit Suisse Group | |
| 28.04.21 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.04.21 | UBS Hold | Deutsche Bank AG | |
| 28.04.21 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group | |
| 28.04.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 28.04.21 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 28.04.21 | Novartis buy | Deutsche Bank AG | |
| 28.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.21 | UBS overweight | JP Morgan Chase & Co. | |
| 28.04.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 28.04.21 | UBS buy | UBS AG | |
| 28.04.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 27.04.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 27.04.21 | Novartis buy | Jefferies & Company Inc. | |
| 27.04.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley |